Decoding the signs of response to cancer immunotherapy

Decoding the signs of response to cancer immunotherapy

Decoding the signs of response to cancer immunotherapy

For some cancer patients, immunotherapy may be way to skip surgery and chemo

Immunotherapy let some cancer patients with mismatch repair deficient tumors completely avoid surgery, chemo and radiation, a clinical trial finds.

BriaCell Therapeutics Raises $13.8 Million in Public Offering to Advance Cancer Immunotherapy Research

BriaCell Therapeutics Corp., a clinical-stage biotechnology company, announced the completion of a public offering that will provide critical funding for its cancer research initiatives. The company raised approximately $13.8 million through the sale of 3,066,666 units, with each unit priced at $4.50. The offering, led by ThinkEquity, includes one common share or pre-funded warrant and one warrant exercisable at $5.25 per share. The transaction …

Clinical Perspectives: Importance of Vaccinations and Infection Prevention Post CAR T, and Monitoring Strategies for Other Potential Late CAR T–Related Toxicities in R/R MM

Experts discuss strategies for managing and mitigating early vs late chimeric antigen receptor (CAR) T-cell therapy–related toxicities, offering advice to practitioners, and share additional clinical pearls on improving the overall CAR T process in academic and community settings.

Immunotherapy Could Replace Surgery for Certain Types of Cancer, New Study Finds

Results from a groundbreaking clinical trial could soon change the way certain types of cancers are treated. A study published Sunday in the New England Journal of Medicine found that immunotherapy could replace surgery for patients with locally advanced mismatch repair-deficient (MMRd) solid tumors — which would preserve their quality of life. What is immunotherapy for cancer? According to the American Cancer Society, immunotherapy is a type of…

Immunotherapy Drugs: A Hopeful Alternative to Invasive Surgeries and Strenuous Treatments for Cancer Patients

When individuals develop solid tumors in the stomach, esophagus, or rectum, oncologists have established treatment strategies. Yet, these treatments can significantly affect quality of life, leading to outcomes such as stomach and bladder removal, permanent colostomy bags, radiation exposure, infertility from chemotherapy, and lasting bodily harm. In response, a research team at Memorial Sloan Kettering [...] Source The post Immunotherapy Drugs:…